WT1 Antikörper (N-Term)
Kurzübersicht für WT1 Antikörper (N-Term) (ABIN927690)
Target
Alle WT1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Bindungsspezifität
 - N-Term
 - 
                                            
Aufreinigung
 - Purified
 - 
                                            
Immunogen
 - WT1 antibody was raised in rabbit using the N terminal of WT1 as the immunogen
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - 
                        WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - 
                                            
Kommentare
 - 
                        
WT1 Blocking Peptide, (ABIN5617029), is also available for use as a blocking control in assays to test for specificity of this WT1 antibody
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Konzentration
 - Lot specific
 - 
                                            
Buffer
 - Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
 - 
                                            
Handhabung
 - Avoid repeated freeze/thaw cycles.
 - 
                                            
Lagerung
 - 4 °C/-20 °C
 - 
                                            
Informationen zur Lagerung
 - Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
 
 - 
                                            
 - 
    
- WT1 (Wilms Tumor 1 (WT1))
 - 
                                            
Andere Bezeichnung
 - WT1
 - 
                                            
Hintergrund
 - WT1 is a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilm's tumors. Multiple transcript variants, resulting from alternative splicing at two coding exons, have been well characterized. There is also evidence for the use of non-AUG (CUG) translation initiation site upstream of, and in-frame with the first AUG, leading to additional isoforms. Synonyms: Polyclonal WT1 antibody, Anti-WT1 antibody, Wilms tumor 1 antibody, AWT1 antibody, GUD antibody, WAGR antibody, WIT-2 antibody, WT33 antibody.
 - 
                                            
Pathways
 - Tube Formation
 
Target
 -